Search

Search Results

1. The Neuromodulatory Effect of Antipruritic Treatment of Chronic Prurigo

   Chronic prurigo is an extremely severe pruritic skin disease which presents with multiple, hyperkeratotic and erosive papules, nodules and/or...

   Claudia Zeidler, Manuel Pereira, Sonja Ständer in Dermatology and Therapy

   Article Open access 11 September 2019

2. AtopyReg^®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

   Background and Objective

   AtopyReg ^® is a multicenter, prospective, observational, non-profit cohort study on moderate-to-severe atopic dermatitis in...

   Luca Stingeni, Andrea Chiricozzi, ... Enrico Pascucci in American Journal of Clinical Dermatology

   Article Open access 19 September 2023
   

3. Dupilumab-Associated Arthritis: A Dermatology-Rheumatology Perspective

   Dupilumab is an interleukin (IL)-4/13 inhibitor approved by the US FDA for multiple atopic indications. It is well-known to have favorable efficacy...

   Michael J. Woodbury, Jeffrey S. Smith, Joseph F. Merola in American Journal of Clinical Dermatology

   Article 22 June 2023
   

4. Neuer Ansatz bei Immunthrombozytopenie

   Redaktion Facharztmagazine in Pädiatrie

   Article 19 June 2024

5. Dupilumab

   in Reactions Weekly

   Article 15 October 2022

6. Diagnosis of Allergic Dermatoses in Skin of Color

   Purpose of Review

   This review aims to deliver a comprehensive report of the most recent knowledge on diagnosing allergic dermatoses in skin of color...

   Angelica Nazarian, Andrew F. Alexis in Current Allergy and Asthma Reports

   Article 22 May 2024
   

7. What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus

   Cutaneous T-cell lymphomas are a heterogenous group of lymphomas that cause various skin manifestations. Severe pruritus occurs frequently in...

   Georgia Biazus Soares, Joan Guitart, Gil Yosipovitch in American Journal of Clinical Dermatology

   Article 16 November 2023
   

8. Altersekzeme und deren Therapie

   Eczema encompass a wide range of dermatoses that can affect elderly patients in particular. Common differential diagnoses in elderly patients include...

   Leonard Harries, Stephan Traidl, ... Thomas Werfel in Die Dermatologie

   Article 28 August 2023
   

9. Ixekizumab/methotrexate

   in Reactions Weekly

   Article 28 October 2023

10. An Haut-Hirn-Achse ansetzen und Juckreiz lindern

    in hautnah

    Article 22 March 2024

11. Overview of use, efficacy, and safety of dupilumab in complex patients: a retrospective, case-series study from a large, urban academic center

    Dupilumab has emerged as an effective treatment option for those suffering from moderate-to-severe atopic dermatitis (AD). Since its approval in 2017...

    Danitza Lukac, Kyla Pagani, Jean S. McGee in Archives of Dermatological Research

    Article 18 June 2022

12. AZD-1222

    in Reactions Weekly

    Article 08 April 2023

13. Secukinumab

    in Reactions Weekly

    Article 12 August 2023

14. Therapie-Update zur atopischen Dermatitis

    Atopic dermatitis (AD) is a common, chronic inflammatory skin disease characterized by a complex pathogenesis, clinical heterogeneity, and relapsing...

    Elisabeth Riedl in hautnah

    Article Open access 05 April 2024
    

15. Urgroßmutter hat die Krätze

    Henning Hamm in MMW - Fortschritte der Medizin

    Article 17 November 2023
    

16. Revolution in der Rhinosinusitis-Therapie

    Nicola Zink in MMW - Fortschritte der Medizin

    Article 22 March 2024
    

17. Den Juck-Kratz-Kreislauf durchbrechen

    Nicola Zink in hautnah dermatologie

    Article 25 July 2022
    

18. Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata

    For decades, contact immunotherapy with dinitrochlorobenzene, diphencyprone, and squaric acid dibutylester has played an important role in both...

    Kun-Wei Lai, Tsen-Fang Tsai in Dermatology and Therapy

    Article Open access 22 September 2022
    

19. Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus

    Introduction

    Several systemic therapies have been approved for the treatment of severe AD. In particular, Janus kinase inhibitors (JAKi), including...

    Luigi Gargiulo, Luciano Ibba, ... Alessandra Narcisi in Dermatology and Therapy

    Article Open access 21 March 2024

20. Schweres Asthma bronchiale: Biologika gezielt auswählen

    Nicola Zink in Pneumo News

    Article 26 April 2024